COPD
Inhalation Spray Label Revised to Include New Data, Broader Indication
Inhalation Spray Label Revised to Include New Data, Broader Indication
The FDA has approved new labeling for Boehringer Ingelheim's Stiolto Respimat (tiotropium bromide & olodaterol) Inhalation Spray that includes data showing a meaningful reduction in COPD exacerbations driven by tiotropium.
Read More >>
Psychological Distress and Socioeconomic Status Increase Risk for Chronic Diseases
FDA Approves Treatment Device for Severe Emphysema
Study Suggests an Increase in Monitoring Needed For Patients With Asthma, COPD
COPD Management Strategies and Minimizing Medication Waste in the Hospital Setting
New Digital Platform is Increasing Inhaler Adherence
COPD: Causes, Stages, and Treatments
Improving Lung Function (FEV1) in COPD Through Appropriate Counseling on Use of Inhaled Medications
View more articles >>
Clinical Trials
Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Pulmonary Rehabilitation Innovation and Microbiota in Exacerbations of COPD
Clinical Impact of Pharmaceutical Consultations in Patients Treated for Chronic Obstructive Pulmonary Disease at Home
Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control Trial
Short Compared With Standard Duration of Antibiotic Treatment for AECOPD
Multimedia: Videos
How to Improve Patient Adherence to Long-Term Asthma and COPD Treatment
How to Improve Patient Adherence to Long-Term Asthma and COPD Treatment
How Pharmacists Can Help Patients Remember Which Medication Is Used for Which Problem
How Pharmacists Can Help Patients Remember Which Medication Is Used for Which Problem
Counseling Points Pharmacists Should Make When Demonstrating Proper Inhaler Use
Counseling Points Pharmacists Should Make When Demonstrating Proper Inhaler Use
How Technology Is Changing the Inhaler Industry
How Technology Is Changing the Inhaler Industry